مصروفات التشغيل تغيير تاريخ
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Celltrion KRW 133.99B 14.77B 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Divis Laboratories Ltd INR 22.52B 3.01B 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
MacroGenics USD 25.15M 17.72M 2026-09
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 100.45M 30.86M 2026-06
Ovoca Bio EUR 173K 990K 2025-12
Pfizer USD 89B 3.81B 2026-09
Pharma Mar EUR 46.77M 4.24M 2026-09
Qiagen NV USD 393.64M 17.95M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.51B 598M 2026-09
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Sartorius EUR 746.5M 1.3M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Takeda JPY 981.78B 36.71B 2026-09
Tilray USD 237.52M 17.34M 2025-09
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09